DRAP Guidelines on National Pharmacovigilance System: Overview
The article provides a general overview of the pharmacovigilance system, highlighting the key points and aspects.
The article provides a general overview of the pharmacovigilance system, highlighting the key points and aspects.
The article outlines the key points associated with the testing medical devices should undergo in order to be allowed for marketing and use in Egypt.
The new article provides further clarifications on the applicable classification system, as well as testing requirements to be considered.
The new article explains the approach to be applied with respect to clinical investigations.
The new article provides further clarifications regarding the design of a clinical study, as well as the risk management approach to be followed.
Gartner® Market Guide for Life Science Regulatory Information Management Solutions
Download NowGartner® Market Guide for Regulatory Intelligence Solutions
Download Now